May, 2021

Moderna founder launches new biotech, looking to cure diseases through 'endless RNA'

Bio Pharma Dive

Laronde comes equipped with $50 million in funding from Flagship Pioneering and a goal to upend how diseases are treated with long-lasting RNA medicines

RNA 273

Thoughts on working with and in the pharma industry

World of DTC Marketing

THOUGHT: I love working in the pharma industry. Yes, I have been critical of the industry because I believe there is too much focus on pleasing Wall Street, yet I believe that there are some really good people starting to climb the ladder and that soon we’ll see some really substantial changes.

Drugs 165
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

In the News: April 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. FDA’s Accelerated Approval Program Comes Under Fire.

To prevent next pandemic, scientists say we must regulate air like food and water

Scienmag

Credit: Martin Visser, Unsplash Humans in the 21st century spend most of their time indoors, but the air we breathe inside buildings is not regulated to the same degree as the food we eat and the water we drink.

After Months of Prodding, CDC Updates Guidance on COVID-19 Airborne Transmission

BioSpace

The CDC says that COVID-19 is an airborne threat, stating that transmission and subsequent infection can occur via inhalation of very fine respiratory droplets and aerosolized particles

114
114

From Insurance Claim Denials to Smiles, Payment and Feeling Empowered

Triage Cancer

Have you ever received a denial from your insurance company? Me too. Just days before my scheduled breast reconstruction surgery. You probably know how I felt. Blindsided. Frustrated. Angry. . I won't make you read this whole article to learn that I appealed that denial and won.

77

Two biotechs team up to bring CRISPR to 'natural killer' cell therapy

Bio Pharma Dive

A wide-ranging alliance between CRISPR Therapeutics and Nkarta is the latest sign of interest in a fast-emerging form of cancer immunotherapy

282
282

More Trending

FDA INTERACT Meetings: Early Interactions for Cell and Gene Therapy Sponsors

Camargo

Advances in scientific knowledge and growth in the cell and gene therapy space have led to a new and exciting era of medicine for patients, as well as a new motivation for regulators to provide clear, efficient pathways for product developers.

Life may have become cellular by using unusual molecules

Scienmag

All modern life is cellular, but how life came to be cellular remains uncertain. New research suggests chemical compounds likely common on primitive Earth may have helped scaffold the emergence of biological cellularity. Credit: Tony Z.

NurOwn: A Study in the Complexity of ALS Trials

BioSpace

There is also a tacit acknowledgment in the industry that the ALSFRS-R (revised) scale needs to evolve

Trials 110

Biden Backs Suspending Patents on Covid Vaccines

NY Times

The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines.

Pharma erupts as Biden administration backs waiver of vaccine patent rights

Bio Pharma Dive

The shift in U.S. policy might not undermine future research as the drug industry claims. Easing patent protections, though, isn't likely to translate to an immediate boost in vaccine supply

Drugs 257

Pfizer wants it all

World of DTC Marketing

QUICK THOUGHT: Pfizer has already made $24 billion from their COVID vaccine, but that’s not enough; they want more, a lot more. They are planning to increase the vaccine price, and they’re working on an oral pill that could bring in as much as an additional $2 billion. While the U.S.

Tackling diabetes & ALS with cell therapy

Pharma Phorum

Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral sclerosis (ALS) and diabetes.

Using micro-sized cut metal wires, Japanese team forges path to new uses for terahertz waves

Scienmag

Credit: Takehito Suzuki, Tokyo University of Agriculture and Technology Japanese researchers successfully tested reflectionless, highly refractive index metasurface that may eventually be used in practical applications to send, receive, and manipulate light and radio waves in the terahertz waveband (THz).

Rare Disease Companies Unite to Advocate for Life-Changing Therapies

BioSpace

The Rare Disease Company Coalition’s 10 founding members have brought 22 treatments to market and currently have more than 160 rare disease programs in the works

Janssen seeks EU approval for first CAR-T therapy cilta-cel

Pharma Times

Cilta-cel is an investigational CAR-T cell therapy for the treatment of relapsed/refractory multiple myeloma

98

Pfizer forecasts $26B in coronavirus vaccine revenue this year

Bio Pharma Dive

The sum is $11 billion higher than Pfizer had estimated in February and, if realized, would make the vaccine the highest grossing pharmaceutical product by revenue in a single year

The responsibility for chronic health issues

World of DTC Marketing

IN SUMMARY: Hypertension, diabetes, and obesity drive a lot of healthcare costs, and the obesity epidemic may be one of the root causes of the rise in rates of hypertension, diabetes and even certain types of cancer.

Why relationships are key in rare disease patient engagement

Pharma Phorum

Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a broader view of their lived experiences, says Xperiome’s Jeremy Edwards.

Force-sensing PIEZO proteins are at work in plants, too

Scienmag

With $52 Million Series A, Appia Bio Anticipates a Bright Future in Cell Therapy

BioSpace

Appia is developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients

7 Best Metformin Alternatives For Type 2 Diabetes

Druggist

Metformin is the most commonly prescribed medication for the treatment of diabetes in the UK. It is also one of the most prescribed drugs overall in the UK. As with other drugs, it is possible to experience side effects during the treament or medicine may not be suitable.

Fate offers glimpse at 'natural killer' cell therapy for leukemia

Bio Pharma Dive

The biotech's treatment is part of a wave of new treatments meant to mimic the effects of natural killer cell transplants in leukemia, though analysts remain skeptical

219
219

Pharma’s paid media fails

World of DTC Marketing

The Washington Post reported last year that health and pharmaceutical companies spent almost $1 billion on just Facebook mobile ads in 2019. A complete waste of money, time and effort.

performance-io adds Jason McKenna as a non-executive director

Pharma Phorum

UK-based performance-io has added to its senior team through two promotions and the appointment of STEM Healthcare CEO Jason McKenna as a non-executive director.

Sales 93

Serotonin transporters increase when depression fades, study shows

Scienmag

Credit: Lou Almskog Low levels of serotonin in the brain are seen as a possible cause of depression and many antidepressants act by blocking a protein that transports serotonin away from the nerve cells.

COVID-19 May Increase Risk of Diabetes, New Study Claims

BioSpace

Patients without diabetes who develop COVID-19 may be at a higher risk of actually developing diabetes following recovery, recent study claims

Celevac discontinued: What are Celevac alternatives?

Druggist

Are you are one of few last patients who still get Celevac prescribed? Unfortunately, Celevac was discontinued , and now it is impossible to get it on prescription or purchase from the pharmacy.

FDA authorizes Pfizer's coronavirus vaccine for younger teens

Bio Pharma Dive

The emergency clearance greatly expands the pool of people who can be vaccinated in the U.S. just as some states are beginning to report waning demand

Corporations: “get healthcare costs under control”

World of DTC Marketing

SUMMARY: A new survey from the Kaiser Family Foundation and the Purchaser Business Group on Health shows signs that corporate executives might be warming to the idea of government getting more involved to rein in the excesses of the healthcare system.

Is digital mental health the key to tackling a deepening crisis?

Pharma Phorum

In an exclusive feature for pharmaphorum, British Liberal Democrat politician, solicitor and mental health campaigner Sir Norman Lamb discusses why digital mental health services can help tackle the escalating mental health crisis.

Fruit flies and mosquitos are ‘brainier’ than most people suspect, say scientists

Scienmag

Findings provide baseline number of brain cells likely needed for complex behaviors Credit: Joshua Raji and Christopher Potter, Johns Hopkins Medicine.

Pfizer/BioNTech and Moderna Seek Full FDA Approval for COVID-19 Vaccines

BioSpace

Six months after receiving Emergency Use Authorization from the U.S. FDA for COVID-19 vaccines, Pfizer/BioNTech and Moderna are planning to seek full approval for the preventative medications

Labcorp Announces Proposed Sale of Senior Notes

BioTech 365

Labcorp Announces Proposed Sale of Senior Notes Labcorp Announces Proposed Sale of Senior Notes BURLINGTON, N.C.–(BUSINESS

Sales 56

Roivant valued at $7B in blank-check merger, bucking SPAC slowdown

Bio Pharma Dive

Vivek Ramaswamy's unusual biotech holding company will go public through a deal with Montes Archimedes Acquisition Corp. that nets Roivant $611 million

218
218

Pharma panics over patent wavers

World of DTC Marketing

WHAT NOW? The Biden administration’s decision to support a temporary waiver of Covid-19 vaccine patents prompted instant outrage in the pharma sector, which argues that the move rides roughshod over their intellectual property rights and will discourage US innovation while sending jobs abroad.

Drugs 165